MVM Partners, LLC
Follow13F filer, CIK 1947083, BOSTON, MA
MVM Partners, LLC reported $91,686,594 across 3 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-01.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0002039852-24-000036
- Period
- 2024-09-30
- Reported value
- $91.7M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MDXHadded | +150,000 | $310K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0002039852-24-000036, largest first. % of portfolio is the value over $91,686,594, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| PARAGON 28 INCPARAGON 28 INC | 10,886,145 | $72.4M | 79.02% | 0 | |||
| MDXHMDXHEALTH SA | 4,700,457 | $9.71M | 10.59% | +150,000 | Timeline | ||
| OPTINOSE INCOPTINOSE INC | 14,605,263 | $9.53M | 10.4% | 0 |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0002039852-24-000036 | base | 2024-11-01 | acceptance time not in the bulk data set |